NLSP
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- NLS Pharmaceutics and Kadimastem announce strategic collaboration between Kadimastem and TargetGene to advance next-generation gene-edited cell therapiesOct 27, 2025
- NLS Pharmaceutics and Kadimastem announce Hong Kong patent covering cell-selection and enrichment technology for IsletRx for diabetes patientsSep 4, 2025